4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-23-043979
General Counsel sold 1,420 shares at $9.65 ($13,710)
- General Counsel acquired 3,924 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ring Christine General Counsel | 2023-07-30 | Option exercise | +1,924 | 11,964 | D | ||
| Ring Christine General Counsel | 2023-07-30 | Option exercise | +2,000 | 13,964 | D | ||
| Ring Christine General Counsel | 2023-07-31 | Sale | −1,420 | $9.65 | $13,710 | 12,544 | D |
| Derivatives | |||||||
| Ring Christine General Counsel | 2023-07-30 | Option exercise · Restricted Stock Units | −1,924 | 19,241 | D | ||
| Ring Christine General Counsel | 2023-07-30 | Option exercise · Restricted Stock Units | −2,000 | 22,000 | D | ||
| Open-market sales · 1,420 sh · avg $9.65 · $13,710 | |||||||
Loading xslF345X05/doc4.xml…